文献速递泌尿生殖技术与安全MR

多区域影像基因组学评估前列腺腺癌腺体微环境:多参数MR成像与DNA全外显子组测序

Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma.
PubMed 文献 · Radiology · 2017-04-28

本研究对6例前列腺腺癌患者行机器人前列腺切除术后,在23个空间定位区域(含组织病理学证实的正常区与异常区)行多参数MR成像与全外显子组DNA测序(覆盖度>50次),以评估腺体微环境的基因组变异。结果显示层次聚类可将组织病理学证实的高级别病变与正常区分开,且与多参数MR成像结果一致;癌症相关基因突变负荷在各区域间无显著差异(P = .30)。主成分分析可区分不同患者样本,并进一步将Gleason评分3+4与4+5腺体的样本分类。

要点

  • 多参数MR成像与组织病理学结果在所有患者中表现一致。
  • 层次聚类可将组织病理学证实的高级别病变与正常区分开。
  • 癌症相关基因突变负荷在各影像/病理区域间无显著差异(P = .30)。

核心结论

  • 多区域空间多参数MR成像与全外显子组影像基因组学分析显示,组织学证实的正常区与高级别病变区之间存在突变的连续谱。

研究设计与样本

  • 研究纳入6例前列腺腺癌患者,均行机器人前列腺切除并全载保存前列腺,以实现术前多参数MR成像与腺体的空间对应;每例腺体确定4个感兴趣区(含组织病理学证实的正常区与异常区),对每个空间定位区域行全外显子组DNA测序(覆盖度>50次);采用层次聚类、系统发育分析和主成分分析进行影像基因组学分析。

关键影像表现/征象

  • 层次聚类将组织病理学证实的高级别病变与正常区分开,且在所有患者中反映多参数MR成像与组织病理学结果的一致性。

诊断标准与关键数值

  • 6例中3例Gleason评分3+4、3例Gleason评分4+5,共分析23个空间独立区域。
  • 在23个前列腺样本中鉴定出涉及29个癌症相关基因的77个突变。
  • 组织病理学证实正常区突变负荷34个突变/样本±19,多参数MR成像轻度可疑区37个突变/样本±21,中度可疑区31个突变/样本±15,高级别癌区33个突变/样本±18,各组间无显著差异(P = .30)。
  • 主成分分析可区分不同患者样本,并进一步将Gleason评分3+4与4+5腺体的样本分类(不论组织病理学状态)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To assess the underlying genomic variation of prostate gland microenvironments of patients with prostate adenocarcinoma in the context of colocalized multiparametric magnetic resonance (MR) imaging and histopathologic assessment of normal and abnormal regions by using whole-exome sequencing. Materials and Methods Six patients with prostate adenocarcinoma who underwent robotic prostatectomy with whole-mount preservation of the prostate were identified, which enabled spatial mapping between preoperative multiparametric MR imaging and the gland. Four regions of interest were identified within each gland, including regions found to be normal and abnormal via histopathologic analysis. Whole-exome DNA sequencing (>50 times coverage) was performed on each of these spatially targeted regions. Radiogenomic analysis of imaging and mutation data were performed with hierarchical clustering, phylogenetic analysis, and principal component analysis. Results Radiogenomic multiparametric MR imaging and whole-exome spatial characterization in six patients with prostate adenocarcinoma (three patients, Gleason score of 3 + 4; and three patients, Gleason score of 4 + 5) was performed across 23 spatially distinct regions. Hierarchical clustering separated histopathologic analysis-proven high-grade lesions from the normal regions, and this reflected concordance between multiparametric MR imaging and resultant histopathologic analysis in all patients. Seventy-seven mutations involving 29 cancer-associated genes across the 23 spatially distinct prostate samples were identified. There was no significant difference in mutation load in cancer-associated genes between regions that were proven to be normal via histopathologic analysis (34 mutations per sample ± 19), mildly suspicious via multiparametric MR imaging (37 mutations per sample ± 21), intermediately suspicious via multiparametric MR imaging (31 mutations per sample ± 15), and high-grade cancer (33 mutations per sample ± 18) (P = .30). Principal component analysis resolved samples from different patients and further classified samples (regardless of histopathologic status) from prostate glands with Gleason score 3 + 4 versus 4 + 5 samples. Conclusion Multiregion spatial multiparametric MR imaging and whole-exome radiogenomic analysis of prostate glands with adenocarcinoma shows a continuum of mutations across regions that were found via histologic analysis to be high grade and normal. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Jamshidi N, Margolis DJ, Raman S, et al. Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma. Radiology. 2017. PMID: 28453432. doi:10.1148/radiol.2017162827

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。